Diagnosis and treatment with steroids for patients with Duchenne muscular dystrophy: experience and recommendations for Mexico
*Correspondencia: Dra. Norma Alejandra Vázquez Cárdenas. Asociación de Distrofia Muscular de Occidente A.C. Román Morales, 284. Sector Libertad. Guadalajara, Jalisco, México.
E-mail: avc200180@yahoo.com.mx
Duchenne muscular dystrophy is a severe, debilitating and progressive disease that affects 1 in 3,500 live male births in the world. The diagnosis should be confirmed by genetic testing to identify the mutation in the DMD gene or muscle biopsy and immunostaining to demonstrate the absence of dystrophin. Although up to now continues to be an incurable disease, this does not mean it has no treatment. Treatment should be multidisciplinary, looking for the functionality of the patient and avoiding or correcting complications, mainly cardio-respiratory and skeletal. Many proposals have been evaluated and implemented with the aim of improving the quality of life for these patients. The long-term steroids have shown significant benefits, such as prolonging ambulation, reduce the need for spinal surgery, improve cardiorespiratory function and increase survival and the quality of life. This document presents the recommendations based on the experience of the working group and experts worldwide on the diagnosis and treatment with steroids for patients with Duchenne muscular dystrophy.
